TAŞTEKİN, D. Et Al. 2014. Synuclein-gamma predicts poor clinical outcome in esophageal cancer patients. TUMOR BIOLOGY , vol.35, no.12 , 11871-11877.

TAŞTEKİN, D., Kargin, S., KARABULUT, M., Yaldiz, N., Tambas, M., Gurdal, N., ... Tatli, A. M.(2014). Synuclein-gamma predicts poor clinical outcome in esophageal cancer patients. TUMOR BIOLOGY , vol.35, no.12, 11871-11877.

TAŞTEKİN, Didem Et Al. "Synuclein-gamma predicts poor clinical outcome in esophageal cancer patients," TUMOR BIOLOGY , vol.35, no.12, 11871-11877, 2014

TAŞTEKİN, Didem Et Al. "Synuclein-gamma predicts poor clinical outcome in esophageal cancer patients." TUMOR BIOLOGY , vol.35, no.12, pp.11871-11877, 2014

TAŞTEKİN, D. Et Al. (2014) . "Synuclein-gamma predicts poor clinical outcome in esophageal cancer patients." TUMOR BIOLOGY , vol.35, no.12, pp.11871-11877.

@article{article, author={Didem TAŞTEKİN Et Al. }, title={Synuclein-gamma predicts poor clinical outcome in esophageal cancer patients}, journal={TUMOR BIOLOGY}, year=2014, pages={11871-11877} }